WO1998006876A1 - Device and methods for remotely induced thermal transduction in chemical and biochemical reactions - Google Patents
Device and methods for remotely induced thermal transduction in chemical and biochemical reactions Download PDFInfo
- Publication number
- WO1998006876A1 WO1998006876A1 PCT/US1997/014307 US9714307W WO9806876A1 WO 1998006876 A1 WO1998006876 A1 WO 1998006876A1 US 9714307 W US9714307 W US 9714307W WO 9806876 A1 WO9806876 A1 WO 9806876A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- support
- temperature
- dna
- heat
- radio frequency
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 50
- 238000006243 chemical reaction Methods 0.000 title claims abstract description 36
- 238000005842 biochemical reaction Methods 0.000 title claims abstract description 14
- 239000000126 substance Substances 0.000 title abstract description 14
- 230000026683 transduction Effects 0.000 title abstract description 13
- 238000010361 transduction Methods 0.000 title abstract description 13
- 230000005672 electromagnetic field Effects 0.000 claims abstract description 18
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 7
- 230000007423 decrease Effects 0.000 claims abstract description 6
- 239000001226 triphosphate Substances 0.000 claims abstract description 3
- 235000011178 triphosphate Nutrition 0.000 claims abstract description 3
- 239000007788 liquid Substances 0.000 claims description 7
- 239000000376 reactant Substances 0.000 claims description 7
- 230000001351 cycling effect Effects 0.000 claims description 2
- 150000007523 nucleic acids Chemical class 0.000 claims 5
- 102000039446 nucleic acids Human genes 0.000 claims 5
- 108020004707 nucleic acids Proteins 0.000 claims 5
- 239000002773 nucleotide Substances 0.000 claims 1
- -1 nucleotide triphosphates Chemical class 0.000 claims 1
- 239000013615 primer Substances 0.000 abstract description 30
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 abstract description 10
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 abstract description 10
- 238000010586 diagram Methods 0.000 abstract description 10
- 239000003155 DNA primer Substances 0.000 abstract description 5
- 239000012807 PCR reagent Substances 0.000 abstract description 5
- 108020001019 DNA Primers Proteins 0.000 abstract description 2
- 125000002264 triphosphate group Chemical class [H]OP(=O)(O[H])OP(=O)(O[H])OP(=O)(O[H])O* 0.000 abstract description 2
- 230000001737 promoting effect Effects 0.000 abstract 1
- 238000010438 heat treatment Methods 0.000 description 42
- 108020004414 DNA Proteins 0.000 description 35
- 230000005684 electric field Effects 0.000 description 28
- 238000003752 polymerase chain reaction Methods 0.000 description 26
- 239000000463 material Substances 0.000 description 24
- 239000011324 bead Substances 0.000 description 20
- 238000000137 annealing Methods 0.000 description 18
- 229910001868 water Inorganic materials 0.000 description 16
- 230000003993 interaction Effects 0.000 description 14
- 238000006116 polymerization reaction Methods 0.000 description 14
- 102000004190 Enzymes Human genes 0.000 description 13
- 108090000790 Enzymes Proteins 0.000 description 13
- 238000004925 denaturation Methods 0.000 description 13
- 230000036425 denaturation Effects 0.000 description 13
- 150000003839 salts Chemical class 0.000 description 12
- AYTAKQFHWFYBMA-UHFFFAOYSA-N chromium(IV) oxide Inorganic materials O=[Cr]=O AYTAKQFHWFYBMA-UHFFFAOYSA-N 0.000 description 11
- 230000008569 process Effects 0.000 description 11
- 230000000694 effects Effects 0.000 description 10
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 10
- 229910052751 metal Inorganic materials 0.000 description 10
- 239000002184 metal Substances 0.000 description 10
- 239000002953 phosphate buffered saline Substances 0.000 description 10
- 239000000243 solution Substances 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 230000027455 binding Effects 0.000 description 9
- 230000005291 magnetic effect Effects 0.000 description 9
- 239000000203 mixture Substances 0.000 description 9
- 239000007787 solid Substances 0.000 description 9
- 230000003321 amplification Effects 0.000 description 8
- 239000004615 ingredient Substances 0.000 description 8
- 238000003199 nucleic acid amplification method Methods 0.000 description 8
- 230000001954 sterilising effect Effects 0.000 description 8
- 102000053602 DNA Human genes 0.000 description 7
- 229940090961 chromium dioxide Drugs 0.000 description 7
- IAQWMWUKBQPOIY-UHFFFAOYSA-N chromium(4+);oxygen(2-) Chemical compound [O-2].[O-2].[Cr+4] IAQWMWUKBQPOIY-UHFFFAOYSA-N 0.000 description 7
- 108091034117 Oligonucleotide Proteins 0.000 description 6
- 238000005342 ion exchange Methods 0.000 description 6
- 230000004044 response Effects 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 5
- 239000000872 buffer Substances 0.000 description 5
- 230000005298 paramagnetic effect Effects 0.000 description 5
- 239000012071 phase Substances 0.000 description 5
- 238000012546 transfer Methods 0.000 description 5
- 239000002699 waste material Substances 0.000 description 5
- 230000008901 benefit Effects 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 238000004659 sterilization and disinfection Methods 0.000 description 4
- 108010090804 Streptavidin Proteins 0.000 description 3
- 150000001412 amines Chemical group 0.000 description 3
- 239000011162 core material Substances 0.000 description 3
- 230000001419 dependent effect Effects 0.000 description 3
- 230000002500 effect on skin Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 230000004907 flux Effects 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 230000016507 interphase Effects 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 239000010813 municipal solid waste Substances 0.000 description 3
- 230000002441 reversible effect Effects 0.000 description 3
- 238000012552 review Methods 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical group N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- 235000014469 Bacillus subtilis Nutrition 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 239000003446 ligand Substances 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- 108020004635 Complementary DNA Proteins 0.000 description 1
- 230000004568 DNA-binding Effects 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 241000208125 Nicotiana Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 108091081062 Repeated sequence (DNA) Proteins 0.000 description 1
- 108020004682 Single-Stranded DNA Proteins 0.000 description 1
- 238000000692 Student's t-test Methods 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 235000013405 beer Nutrition 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 239000008364 bulk solution Substances 0.000 description 1
- 238000010804 cDNA synthesis Methods 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000012501 chromatography medium Substances 0.000 description 1
- 230000002301 combined effect Effects 0.000 description 1
- 230000009137 competitive binding Effects 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 230000005685 electric field effect Effects 0.000 description 1
- 239000010408 film Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 238000003505 heat denaturation Methods 0.000 description 1
- 239000008241 heterogeneous mixture Substances 0.000 description 1
- 239000010800 human waste Substances 0.000 description 1
- 230000015784 hyperosmotic salinity response Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910001867 inorganic solvent Inorganic materials 0.000 description 1
- 239000003049 inorganic solvent Substances 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 150000002605 large molecules Chemical class 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 235000021056 liquid food Nutrition 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000002906 medical waste Substances 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 238000001543 one-way ANOVA Methods 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 239000002987 primer (paints) Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000009494 specialized coating Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 239000002887 superconductor Substances 0.000 description 1
- 230000003319 supportive effect Effects 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 238000012353 t test Methods 0.000 description 1
- 238000005382 thermal cycling Methods 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L7/00—Heating or cooling apparatus; Heat insulating devices
- B01L7/52—Heating or cooling apparatus; Heat insulating devices with provision for submitting samples to a predetermined sequence of different temperatures, e.g. for treating nucleic acid samples
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
- B01L2200/06—Fluid handling related problems
- B01L2200/0647—Handling flowable solids, e.g. microscopic beads, cells, particles
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/18—Means for temperature control
- B01L2300/1861—Means for temperature control using radiation
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/18—Means for temperature control
- B01L2300/1861—Means for temperature control using radiation
- B01L2300/1872—Infrared light
Definitions
- the present invention is related to devices and methods useful for reactions requiring thermal modulation.
- the present invention is a device useful for and methods of performing reactions that would benefit from thermal transduction, such as the polymerase chain reaction, using solid paramagnetic supports or magnetic supports to be used in combination with an energy field to generate temperature fluctuations.
- the present invention pertains to chemical and biochemical reactions that require or are benefitted by thermal modulation or transduction.
- One example of such a reaction is the polymerase chain reaction (PCR) .
- PCR has become a technological phenomenon over the last several years and is becoming a central technique employed across a wide range of disciplines and applications.
- the method allows for the effective analysis of trace samples, is straight- forward and robust, and is based on well-characterized and controllable chemical and biochemical reactions.
- the PCR method also has ' several problems that have yet to be resolved. It is relatively expensive, requires a certain amount of expertise in designing optimized amplification protocols, and is dependent on inefficient instrumentation. The reliance of the method on this particular type of instrumentation necessitates the use of thermal -stable enzymes.
- PCR is a set of individual reactions run in repeated sequence and facilitated by a unified buffer system that eliminates all but one type of controlled manipulation between steps.
- the steps include: (1) heat denaturation of duplex DNA in the starting sample, (2) sequence-specific annealing of short oligonucleotide primers and (3) enzyme-mediated elongation of these bound primers into complementary DNA polymers. This is made possible by a buffer system that is comprised of ingredients selected for their ability to perform their primary function while not inhibiting subsequent reactions .
- applied heat is manipulated to control the onset and duration of each of these sequential steps. In a typical PCR reaction, heat is applied to the solution containing the reactants until an endpoint temperature of approximately 94 °C is achieved.
- This reaction temperature initiates denaturation of the double-stranded DNA in the sample.
- the temperature is maintained for a period of time thought to facilitate efficient denaturation and then ramped down to a predetermined temperature thought to induce specific annealing of the added primer molecules to the DNA template.
- PCR results require significant expertise in determining the proper heat balance at the annealing step. If the operator-selected annealing temperature is too high, then the primers either do not anneal at all or anneal in too few numbers to promote good amplification. If the selected temperature is too low, then non-specific interactions are likely to occur.
- the determining factors include primer length, concentration and sequence. (Selected temperatures are normally between 55° and 68°C) .
- the temperature is then ramped up to 72 °C for polymerization.
- This temperature is then ideal for the thermal -stable enzymes required by this approach. This is the step that is unique to the predominant PCR process.
- the use of a thermal -stable enzyme allows the whole process of denaturation, annealing, and polymerization to be repeated many times over with the same enzyme.
- the same thermal -stable property that permits this enzyme to retain function after multiple exposures to the denaturation step also requires ramping up to a temperature intermediate to the denaturation and annealing steps, creating a complex and inefficient heat-chill-heat protocol.
- radio frequency waves are a form of electromagnetic energy. They also transfer energy directly into materials, primarily by the interaction of their time-varying electric fields with molecules.
- Radio frequency waves may be applied by connecting a radio frequency alternating current to a pair of electrodes. Between the two electrodes an alternating radio frequency electromagnetic field having a time-varying electric field component is established. When objects are placed between the electrodes in the time-varying electric field, the time-varying electric field partially or completely penetrates the object and heats it.
- Heat is produced when the time-varying electric field accelerates ions and electrons which collide with molecules. Heat also is produced because the time- varying electric field causes molecules, and particularly those with a relatively high electric dipole moment, to rotate back and forth as a result of the torque placed upon them by the time-varying electric field. Most large molecules, or molecules with evenly distributed charge, have relatively low or nonexistent dipole moments and are not very much affected by the radio frequency time- varying electric field. Small molecules, in particular with polar groups, have relatively large electric dipole moments and thus have relatively large torques exerted upon them by the time-varying electric field.
- a time-varying electric field is always accompanied by a time-varying magnetic field, except where destructive cancellation occurs with interference patterns.
- the principal heating mechanism arises from the electric fields. These fields can cause both ohmic heating via induced ionic currents and dielectric heating via molecular stressing from the internal electric fields.
- the presence of the accompanying time-varying magnetic field can also induce eddy-currents which can also heat the material. Also, some type of combined effect of magnetic fields and heat may occur. While the ensuing discussion is presented in context of an electric field effect, it should be understood that the effects of accompanying time-varying magnetic field are defined here for simplification as part of the electric field phenomena.
- Russian Union Patent No. 1,123,705 discloses a method of sterilizing medical instruments for reuse by UHF treatment. For injection needles it discloses a final temperature of 160°C to 470°C and for acupuncture needles it discloses a final temperature of 160°C to 270°C.
- This system first shreds the waste, sprays the shredded waste with water, and passes the wet shredded waste through a microwave chamber designed to raise the temperature of the wet shredded waste to 205°C to sterilize it. After the sterilization step, the system compresses the sterilized shredded waste and packages it for shipment to landfills or incinerators (The Wall Street Journal, p. B33, Apr. 10, 1989) .
- U.S. Pat. No. 3,547,577 to Loverch discloses a machine for treating garbage by shredding, compressing the shredded garbage into briquettes, and sterilizing the briquettes with gas. After shredding the garbage is separated into magnetic and nonmagnetic portions. The sterilization step employs ethylene gas which requires temperature control . The briquettes are maintained at a temperature of about 54 °C.
- Chipley cited numerous tests of microwaves on microorganisms and concluded that "results of tests for viability of B. subtilis spores also showed identical death curves compared with those obtained by conventional heat.”
- Chipley cites several references which support the view that microwave irradiation has collateral thermal and nonthermal effects.
- Culkin and Fung (1975) found that microbial destruction occurred at reduced temperatures and shorter time periods when the material was exposed to microwaves as compared to conventional heating methods. Wayland, et. a_l . , 1977 also demonstrated the interdependence of heat and microwave effects in the studies of spores of B. subtilis .
- Hayford discloses a radio frequency applicator with electroscopic control for destroying bacteria in bottled beer and similar products. Hayford teaches an apparatus for sterilizing a series of small objects.
- U.S. Pat. No. 3,948,601 to Fraser, et. a_l. teaches the indirect use of radio frequency energy in sterilizing medical and hospital equipment as well as human waste.
- the reference teaches the use of radio frequency energy for heating gases, particularly argon, and exciting them so that they ionize into a plasma having a temperature of approximately 100°C to 500°C.
- the reference teaches that a cool plasma at a temperature of only 25°C to 50°C and very low pressure may effectively sterilize an article.
- microwave heating is a valuable alternative to conventional heating means.
- generalized heating observed would not provide differential or regionalized heating required for certain biochemical and chemical reaction.
- the present invention is a device and method for providing temperature modulation to chemical and biochemical reactions.
- the present invention is a method of elongating a primer molecule annealed to a DNA template.
- This reaction comprises the steps of combining a radio frequency responsive support, in a supportive environment, with a double-stranded DNA template molecule.
- DNA primers, DNA polymerase, deoxynucleotide triphosphates and other reagents necessary to amplify the DNA template would be dispersed in the aqueous phase.
- the support will comprise a means of attaching the template molecules.
- the temperature of the support will increase and the DNA template will become denatured.
- the DNA polymerase then catalyzes the elongation of the primer.
- the support has been derivatized with moieties that attract the DNA molecule to the surface of the support .
- the method is repeated multiple times in order to modulate the reaction temperature multiple times and make multiple copies of the DNA template.
- the invention is a device to modulate chemical and biochemical reaction temperature.
- the device comprises a radio frequency responsive support in an aqueous environment and a means for generating an electromagnetic field.
- Figs. 1A - C depict the role of the radio frequency responsive support in the present invention.
- Fig. 1A diagrams an electrically or radiofrequency responsive conductive support.
- Fig. IB diagrams the attachment of an R group (+) capable of being utilized for reversible binding of the template.
- Fig. 1C diagrams the application of an electromagnetic field to the electrically conductive support.
- Fig. 2 diagrams the relationship of the PCR reagents, including double- stranded DNA template, primers, and DNA polymerase, to the support.
- Fig. 3 diagrams the relationship of the PCR reagents when an electromagnetic field is applied to the support.
- Fig. 4 diagrams the relationship of the PCR components when the electric field is removed from the solid support and the temperature of the heat zone boundary decreases .
- Fig. 5 diagrams the relationship of the PCR reagents to the solid support when the temperature decreases further and DNA polymerase begins to elongate the primer molecules .
- Fig. 6A and B diagram temperature fluctuations in both standard PCR (Fig. 6A) and alternative PCR version 1 (Fig. 6B) .
- Fig. 7A and B describes temperature fluctuations in alternative PCR version 2 (Fig. 7A) and alternative PCR version 3 (Fig. 7B) .
- the present invention is a device useful for and methods of performing reactions that would benefit from thermal transduction and modulation, such as the polymerase chain reaction.
- the invention employs solid radio frequency responsive supports in combination with an energy field to generate temperature fluctuations.
- the present invention provides a way to eliminate the requirement for the thermal -stable DNA polymerase without the necessity of replenishing the denatured polymerase.
- a PCR cycler uses a combination of heaters and chillers to add to or remove the thermal energy in a heat transfer liquid which is then pumped through an aluminum heat exchange block.
- the block features cavities for a number of specially designed thin-walled reaction tubes. These 'tube wells' in the heat exchange block are usually filled with mineral oil by the operator to facilitate heat transfer between the block and the tubes containing the dissolved ingredients.
- the tubes and subsequently the buffer they contain then become the next medium for the transfer of heat to or from the vicinity of those reactants whose proximity and interaction with one another set up the necessary conditionals for the next step in the process .
- the oligonucleotides are added to the mixture in higher molar proportion than the template DNA and thus eventually prevail in capturing available binding sites on the template.
- the permissive temperature for annealing is much lower than the temperature required to induce efficient polymerization with thermal -stable enzymes. Therefore, the next step is to ramp the temperature back up to the higher polymerization temperature.
- This up-down-up, up-down-up cycling adds complexity to the cycler and its control systems. The ramping of temperatures through all the various media adds time and also requires that the entire solution be exposed to heat. These generalized temperature fluxes will unnecessarily destroy the activity of non-thermostable proteins.
- the present invention employs a thermal energy flux.
- the various reaction events are still mediated by controlled heating and cooling, but there are several important differences from the traditional means. Rather than heating from the outside, the proposed system applies heat selectively at the proximity of only those ingredients that require heat. Obviously this requires regionalizing those reagents and conditions and developing a means to selectively heat m that region.
- aqueous solution will typically still be required to contain and disperse the various soluble ingredients of the sample, but in this case it will also serve as a passive heat sink.
- the reactants may be contained within films, waxes, glasses, organic or inorganic solvents, or superconductors or other kinds of catalysts.
- a solid, radio frequency responsive component preferably a magnetic or paramagnetic compound, would serve as a transducer to convert radiated energy into regionalized thermal energy and also as a support for a variety of available chromatography ligands.
- the interphase, or "heat zone boundary,” would serve as the selected region where the various polymerase chain reaction reagents could interact under external control .
- Hysteresis, eddy-current heating or inhibited dipole rotation might provide a means to transduce an emitted radio frequency field into localized heat. These properties can result in a so-called 'skin effect' in some materials that is localized to the surface proximity. This would satisfy the requirement for the regionalized effects that I alluded to earlier.
- Figs. 1 - 5 describe various steps of the current invention.
- the inner circles are intended to represent the cross section of a bead or strand of the radio frequency responsive material described above.
- the inner circle would be comprised of a material whose composition and dimensions are subject to our control (Fig. 1A) .
- an R group such as a quaternary amine, which we could then utilize for reversible ion exchange chromatography.
- the quaternary amine would charge-modify the surface so as to present a net positive charge (+) .
- the negatively charged double- stranded DNA template would be attracted to the surface of the support.
- Negatively charged primers would be inhibited from interaction with the bead through the use of a specific modulator (e.g., salt) . If the core material of the bead or strand were a tuneable transducer then irradiation with radio waves from a remote generator might be used to induce one or more of the heat generating skin effects described above.
- the outer circles in Fig. 1A - C represent a heat zone boundary. This boundary will be used to describe a zone between the bead surface and the true solution phase of the aqueous system and it is within this heat zone boundary that the desired reactions will take place. In one case, this outer circle might delineate a thermocline between the heated solution near the solids' surface and the rest of the aqueous components. In another case it might be used to describe the geometric boundary of the radiant heat which is probably limited as the root function of the distance from the transducer. It might also be used to describe different convection or hydrodynamic properties between the bulk of the solution phase and the film of liquid whose proximity to the surface provides for unique properties.
- the chromatographically functionalized support in this specific example a charge modified ion exchanging bead or strand
- a radio frequency or other electromagnetic field which induces the solid matrix of the support to heat up at its surface (the resulting heat flux is represented by the arrows) .
- This is the transduction event caused by the phenomena of Eddy-Current, Hysteresis or inhibited dipole rotation discussed elsewhere.
- One source of this electromagnetic field could be a device called a "Field Generator. " Depending on the frequency required and the specific electromagnetic phenomenon chosen to generate the heating, this field can be in the portion of the spectrum of electromagnetic emission known as RF (radio frequencies) or might also be a low frequency alternating polarity field.
- Fig. 2 is provided to demonstrate various PCR reagents in context. It is intended to show that, at the beginning of the reaction, the mixture comprising the solution phase contains a relatively homogenous distribution of reagents. However, because of the composite buffer and salt configuration, in this example, duplex template DNA would tend to selectively associate and accumulate by ion exchange with the quaternary amines on the bead surface .
- Other attachment means are possible. (For example, attachment could be via other well known means such as interaction of biotinylated template and streptavidin-coated beads.) This attachment provides the condition required to selectively heat the template DNA during the subsequent denaturation steps. The short primers also present would not tend to accumulate to the surface under these salt conditions.
- the specific salt conditions will need to be determined empirically but will fall between the minimum concentration required to inhibit binding of the oligonucleotide length primers to the charge-modified matrix, the number of charges put on the beads (a factor in our control) and the polymerase 's tolerance to salt. In other similar chromatography media this would extend from between O and 500 mM.
- the maximum salt concentration would be delineated by the salt tolerance of the polymerase used. 50-200 mM is a typical range for some polymerases . For those polymerases obtained from halophilic organisms the tolerance could be much higher.
- Fig. 3 shows the effects on those molecules that happen to be in close proximity with the surface of the support when the generator is turned on and the . electromagnetic field is applied to the support.
- the intended heat target (template DNA) is denatured by this heating. This is a necessary step to provide access for the oligonucleotide primers during the subsequent annealing step. Note that if a non-thermal- stable polymerase happens to be in the effective heating range of the bead, it could become irreversibly denatured. Also note, however, that the vast bulk of the enzyme is located outside the effective heating zone and is therefore unaffected by this heating step. The volume differential between the true solution phase and the film of liquid in the effective zone is in our control and is likely to be many orders greater for the phase outside the heating zone.
- Fig. 4 depicts primer annealing.
- the conditions will be ideal for the sequence- specific oligonucleotide primers to find and bind to complementary stretches of the denatured template DNAs . This binding is different than that between the template and the bead and is specifically promoted by the presence of salts. Salt conditions are set so that the oligonucleotides bind only to the template. Note that under these conditions the oligonucleotides will not interact with template DNA molecules not already denatured. Referring to Fig. 5, as the temperature reaches the ideal range for a particular enzyme being used, the conditions will be sufficient for DNA polymerization.
- both strands of the DNA template will be copied. This means that for every DNA molecule affected two new duplexes will be formed. These steps are initiated by the interaction of bound polymerase which will have migrated in from the surrounding solution. This association is limited by diffusion rates, concentration and the volume differentials involved.
- Figs. 6 and 7 show the necessary heating and cooling profiles for the various amplification procedures discussed above. These are the control steps and therefore represent instrument programming considerations.
- Figs. 6 and 7 show both the standard method currently employed for PCR thermocyclers (Fig. 6A) and a selection of possible versions for the system of the present invention (Fig. 6B, Fig. 7A and B) .
- the standard PCR protocol involves a step-up, step-down, step-up thermal sequence. Because of the thermal masses involved and because of the indirect nature of heating this requires measuring these steps in minutes.
- the programming controls for this system are complex and require significant knowledgeable input on the part of the user. Since existing programs call for specific endpoint temperatures it is up to the operator to calculate or guess at the ideal temperatures for annealing.
- the present invention only requires pressing a 'run' button.
- the proposed heat profile is consistent with each of the steps described above, and especially for the annealing step which benefits when approaching the ideal temperature for primer binding from the high end.
- the protocols described here would probably be measured in seconds instead of minutes . Thus, many more cycles may be possible in less total time .
- the method of the present invention might have only one heating step per cycle as opposed to two for the standard method. Heating could potentially occur in a fraction of a second and heat loss might be accomplished through natural heat decay to the environment . Passive control might be improved by using specialized coatings on the beads to affect the rate of heat loss and, thus, to provide even more effective processing.
- the bulk solution itself might be used as a heat sink without the accumulation of too much heat. If this is possible it might eliminate the need for coolers altogether.
- Fig. 6B diagrams this heating protocol. Because the three steps (denaturation, annealing and polymerization) are done in a sequence with each requiring a lower temperature than the last, far less control may be required. Because different materials have different heat decay properties, heat may be added to the system at more than 1 point during each cycle. For example, see Fig. 7A.
- Fig. 7A the length of time that the sample ingredients experience a particular temperature range is extended by applying some heat throughout the entire process. Since the sequence of events calls for diminishing amounts of heat all we need to do is to delay the decline. This might be done by reducing the power output from the generator or by intermittent full power pulses occurring with ever-diminishing frequency.
- Fig. 7B shows a much more sophisticated profile in which the various physical and biochemical demands of this multistep process are taken into account. It may be determined experimentally that a particular step (eg. denaturation) can only be performed efficiently if the beads are heated for several seconds. Additionally, thermodynamics and diffusion rates might require that annealing take place over a longer period than that allowed for by natural heat loss. And, it is entirely possible that a particular enzyme will require certain minimum times in order to maximize amplification of the template. This accounts for the shallowed slopes depicting the time a sample will be exposed to the temperatures that promote annealing and polymerization.
- a particular step eg. denaturation
- thermodynamics and diffusion rates might require that annealing take place over a longer period than that allowed for by natural heat loss.
- a particular enzyme will require certain minimum times in order to maximize amplification of the template. This accounts for the shallowed slopes depicting the time a sample will be exposed to the temperatures that promote annealing and polymerization.
- Template DNA and a set of oligo nucleotide-length single-stranded primers are added to a "Master Mix" containing the necessary support reagents for DNA polymerization.
- a core master mix c ontaining the normal ingredients necessary for polymerization may oe supplemented or otherwise optimized for transduction heating . It will minimally comprise: dNTPs Building blocks for newly synthesized DNA
- the samples consisting of primers, template and master mix are then added to tubes, or 96 well trays, containing a chromatographically functionalized, radio frequency responsive, transducible support (e.g. ion- exchanging paramagnetic beads or strands) .
- a chromatographically functionalized, radio frequency responsive, transducible support e.g. ion- exchanging paramagnetic beads or strands
- the tubes or trays are then placed in a radio- frequency field generator programmed to perform a controlled series of thermal induction steps that selectively generate heat at the functionalized surface of this support.
- this device will also control the duration of heating and rate of heat loss from the support.
- a spherical, or preferably stranded, radio frequency responsive, metallic support is proposed with a set of particular paramagnetic or electronic properties which can be remotely manipulated to generate localized heating on the surface of the support .
- Thermal energy would be generated by a process of remotely controlled "Skin- Effect” or “Hysteresis Heating.” These phenomena are known to be modulated by radio frequency or other electromagnetic field emissions.
- Example and properties of typically suitable supports are described below in Table 2.
- Two metallic supports, magnetite and chromium dioxide, are compared to PBS and H 2 0.
- the data described in Table 2 were obtained in experiments designed to characterize various materials for radiofrequency response.
- ⁇ Magnetite (Fe 3 0 4 ) and chromium dioxide (Cr0 2 ) were selected to represent magnetically responsive materials that might normally be used as the magnetic cores of supports employed in separation applications.
- Water, PBS and TE were selected to represent some of the most commonly encountered liquid solvents for chemical and biochemical reactions. (The data for TE is not represented in Table 2.)
- the range of frequencies shown are for those cases where one or more of the materials tested showed evidence of radio frequency response.
- Running a multiple, pairwise comparison test indicated that the values obtained for water, PBS and TE are not significantly different from one another. Additionally, the values obtained for magnetite and chromium dioxide are also not significantly different from one another. However, the temperature data obtained from the set of substances including water, PBS, and TE are significantly different from those obtained from the set of substances comprising magnetite and chromium dioxide. The probability that we erroneously concluded that differences truly exist between these 2 sets of substances is P ⁇ 0.05 for the set of 10 pairwise comparisons run.
- Frequency Temp Frequency Temp. Frequency Temp. Frequency Temp. Frequency Temp.
- mW milliwatts
- PBS --phosphate buffered saline PBS --phosphate buffered saline
- nd -not detected not determined.
- a suitable material would typically be functionalized at its surface with one of a variety of specialized ligands that promote reversible binding of DNA to the surface of the support. The efficiency and specificity of the binding interaction could then be controlled by the potential modulators described above and by the heating process itself.
- Instrument A preferable device useful in the method of the present invention is a programmable RF field generator capable of time controlled heating of the functionalized surface of the support and, thus, those components of the reaction that specifically interact with the support.
- power converted by an AC/DC transformer is supplied to a frequency generator which is used to tune specific wavelengths through specially wound field generator coils. The fields from these coils are adjacent to and impinge on samples placed in their proximity. The specific field strengths and frequencies can then be manipulated to remotely induce thermal transduction.
- Heat induction occurs only so long as the field is activated and cooling occurs through natural heat decay from the coated or uncoated surface once the emissions cease or by controlled heat loss by reduction in the power, duration or frequency of the emitted field.
- Ion Exchange is inhibited by increasing salt concentration whereas hydrogen bonding is enhanced.
- magnetite beads will be coated with streptavidin and combined with biotinylated duplex DNA. Because this template DNA has only one biotin group attached to the 5' end of one strand, the interaction with the streptavidin coated beads occurs through one strand only. The complementary strand is thus free to dissociate from the bound strand through thermal denaturation.
- duplex DNA will remain associated with the magnetic beads.
- dNTPs including fluorescent dCTP
- buffers and a primer-dependent DNA polymerase and heated. After heating, the sample will be cooled to allow annealing of the primers to the bound strand. At this point the sample is heated or allowed to cool to an intermediate temperature consistent with the requirements for the selected enzyme to allow polymerization (if any) to occur.
- any ensuing evidence of fluorescence associated with the beads over and above that seen in template-minus control reactions will indicate that annealing of the primers to the template (a necessary prerequisite for polymerization) had been accomplished, and in turn that denaturation (a necessary prerequisite of annealing) of the otherwise stable duplex molecule had in fact occurred. This will demonstrate that the reaction is not blocked by any component when used under external heating conditions and is promoted under internal heating conditions.
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Clinical Laboratory Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU40669/97A AU4066997A (en) | 1996-08-16 | 1997-08-14 | Device and methods for remotely induced thermal transduction in chemical and biochemical reactions |
EP97938302A EP0943011A4 (en) | 1996-08-16 | 1997-08-14 | Device and methods for remotely induced thermal transduction in chemical and biochemical reactions |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US2406596P | 1996-08-16 | 1996-08-16 | |
US60/024,065 | 1996-08-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1998006876A1 true WO1998006876A1 (en) | 1998-02-19 |
Family
ID=21818691
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1997/014307 WO1998006876A1 (en) | 1996-08-16 | 1997-08-14 | Device and methods for remotely induced thermal transduction in chemical and biochemical reactions |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP0943011A4 (en) |
AU (1) | AU4066997A (en) |
WO (1) | WO1998006876A1 (en) |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000047732A1 (en) * | 1999-02-12 | 2000-08-17 | Biotix Gmbh | Method for fractionating double-stranded nucleic acids in solutions in order to obtain single-stranded nucleic acids |
EP1080230A1 (en) * | 1998-05-19 | 2001-03-07 | Cell Robotics, Inc. | Method and apparatus for activating a thermo-enzyme reaction with electromagnetic energy |
WO2001077045A1 (en) * | 2000-04-10 | 2001-10-18 | Flock Stephen T | Energy enhanced reaction catalysis and uses thereof |
DE10036486A1 (en) * | 2000-07-25 | 2002-02-14 | Biotix Gmbh | Process for the separation of double-stranded nucleic acids in solution into single-stranded nucleic acids |
US6673214B1 (en) * | 1999-04-09 | 2004-01-06 | Rocky Mountain Biosystems, Inc. | Energy enhanced reaction catalysis and uses thereof |
WO2004005505A1 (en) * | 2002-06-14 | 2004-01-15 | Council Of Scientific And Industrial Research | A simple, efficient, and accelerated method for enzyme-catalyzed in vitro modification and synthesis of nucleic acid using microwave irradiation |
EP1642648A1 (en) * | 2004-09-30 | 2006-04-05 | Roche Diagnostics GmbH | Apparatus and method for regulating the temperature of a liquid |
US7392718B2 (en) | 2004-11-10 | 2008-07-01 | Canon Kabushiki Kaisha | Sample temperature adjusting system |
US7504219B2 (en) * | 2005-05-13 | 2009-03-17 | Dxna Llc | Methods and apparatus for amplification of DNA using sonic energy |
US7537917B2 (en) | 2006-03-31 | 2009-05-26 | Collins Michael J | Microwave assisted PCR amplification of DNA |
US8236143B2 (en) * | 2002-03-11 | 2012-08-07 | Gr Intellectual Reserve, Llc | Controlling chemical reactions by spectral chemistry and spectral conditioning |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4690130A (en) * | 1985-12-19 | 1987-09-01 | Mirell Stuart G | Electromagnetic therapy control system |
US5411730A (en) * | 1993-07-20 | 1995-05-02 | Research Corporation Technologies, Inc. | Magnetic microparticles |
US5507967A (en) * | 1994-02-14 | 1996-04-16 | Toyohisa Fujita | Electrorheological magnetic fluid and process for producing the same |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4106488A (en) * | 1974-08-20 | 1978-08-15 | Robert Thomas Gordon | Cancer treatment method |
US4154246A (en) * | 1977-07-25 | 1979-05-15 | Leveen Harry H | Field intensification in radio frequency thermotherapy |
US4687895A (en) * | 1984-07-30 | 1987-08-18 | Superwave Technology, Inc. | Conveyorized microwave heating system |
US4679561A (en) * | 1985-05-20 | 1987-07-14 | The United States Of America As Represented By The United States Department Of Energy | Implantable apparatus for localized heating of tissue |
DE3808942A1 (en) * | 1988-03-17 | 1989-09-28 | Bio Med Gmbh Ges Fuer Biotechn | Incubator, in particular for the polymerase chain reaction |
WO1991008308A1 (en) * | 1989-11-30 | 1991-06-13 | Pharmacia Genetic Engineering, Inc. | A new method for detecting a specific nucleic acid sequence in a sample of cells |
AU656556B2 (en) * | 1991-03-13 | 1995-02-09 | Minnesota Mining And Manufacturing Company | Radio frequency induction heatable compositions |
US5498392A (en) * | 1992-05-01 | 1996-03-12 | Trustees Of The University Of Pennsylvania | Mesoscale polynucleotide amplification device and method |
DE4318417A1 (en) * | 1993-06-03 | 1994-12-08 | Juergen Weidner | Mutation determinations with the aid of SSCP |
-
1997
- 1997-08-14 WO PCT/US1997/014307 patent/WO1998006876A1/en active Application Filing
- 1997-08-14 EP EP97938302A patent/EP0943011A4/en not_active Withdrawn
- 1997-08-14 AU AU40669/97A patent/AU4066997A/en not_active Abandoned
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4690130A (en) * | 1985-12-19 | 1987-09-01 | Mirell Stuart G | Electromagnetic therapy control system |
US5411730A (en) * | 1993-07-20 | 1995-05-02 | Research Corporation Technologies, Inc. | Magnetic microparticles |
US5507967A (en) * | 1994-02-14 | 1996-04-16 | Toyohisa Fujita | Electrorheological magnetic fluid and process for producing the same |
Non-Patent Citations (1)
Title |
---|
See also references of EP0943011A4 * |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1080230A1 (en) * | 1998-05-19 | 2001-03-07 | Cell Robotics, Inc. | Method and apparatus for activating a thermo-enzyme reaction with electromagnetic energy |
EP1080230A4 (en) * | 1998-05-19 | 2001-12-12 | Cell Robotics Inc | Method and apparatus for activating a thermo-enzyme reaction with electromagnetic energy |
WO2000047732A1 (en) * | 1999-02-12 | 2000-08-17 | Biotix Gmbh | Method for fractionating double-stranded nucleic acids in solutions in order to obtain single-stranded nucleic acids |
DE19907470A1 (en) * | 1999-02-12 | 2000-08-17 | Thomas Lurz | Process for the separation of double-stranded nucleic acids in solution into single-stranded nucleic acids |
US6673214B1 (en) * | 1999-04-09 | 2004-01-06 | Rocky Mountain Biosystems, Inc. | Energy enhanced reaction catalysis and uses thereof |
WO2001077045A1 (en) * | 2000-04-10 | 2001-10-18 | Flock Stephen T | Energy enhanced reaction catalysis and uses thereof |
WO2002008455A3 (en) * | 2000-07-25 | 2002-08-15 | Biotix Gmbh | Method for unraveling double-stranded nucleic acids located in a solution into single-stranded nucleic acids |
DE10036486A1 (en) * | 2000-07-25 | 2002-02-14 | Biotix Gmbh | Process for the separation of double-stranded nucleic acids in solution into single-stranded nucleic acids |
US8236143B2 (en) * | 2002-03-11 | 2012-08-07 | Gr Intellectual Reserve, Llc | Controlling chemical reactions by spectral chemistry and spectral conditioning |
WO2004005505A1 (en) * | 2002-06-14 | 2004-01-15 | Council Of Scientific And Industrial Research | A simple, efficient, and accelerated method for enzyme-catalyzed in vitro modification and synthesis of nucleic acid using microwave irradiation |
CN1309827C (en) * | 2002-06-14 | 2007-04-11 | 科学与工业研究会 | Simple efficient and accelerated method for enzyme-catalyzed in vitro modification and synthesis of nucleic acid using microwave irradiation |
EP1642648A1 (en) * | 2004-09-30 | 2006-04-05 | Roche Diagnostics GmbH | Apparatus and method for regulating the temperature of a liquid |
US7392718B2 (en) | 2004-11-10 | 2008-07-01 | Canon Kabushiki Kaisha | Sample temperature adjusting system |
US7504219B2 (en) * | 2005-05-13 | 2009-03-17 | Dxna Llc | Methods and apparatus for amplification of DNA using sonic energy |
US7537917B2 (en) | 2006-03-31 | 2009-05-26 | Collins Michael J | Microwave assisted PCR amplification of DNA |
Also Published As
Publication number | Publication date |
---|---|
EP0943011A1 (en) | 1999-09-22 |
EP0943011A4 (en) | 2004-03-31 |
AU4066997A (en) | 1998-03-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1998006876A1 (en) | Device and methods for remotely induced thermal transduction in chemical and biochemical reactions | |
US5288471A (en) | Apparatus for preserving biological products | |
EP0796345B1 (en) | An apparatus for performing magnetic cycle reaction | |
TWI290583B (en) | Apparatus and method for purification of nucleic acids by phase separation using laser and beads | |
Sanz et al. | Modelling of reactivation after UV disinfection: effect of UV-C dose on subsequent photoreactivation and dark repair | |
Sastry | Advances in ohmic heating and moderate electric field (MEF) processing | |
EP0553377A1 (en) | Energy-efficient electromagnetic elimination of noxious biological organisms | |
WO1997047767A1 (en) | Microfluidic method for nucleic acid amplification | |
GR3020867T3 (en) | Microwave modification of biological macromolecules. | |
WO2000036880A3 (en) | Microwave apparatus and methods for performing chemical reactions | |
EP0967274A3 (en) | Method for purification of covalently closed DNA-molecules | |
CA2445776A1 (en) | Differential photochemical & photomechanical processing | |
Derry | CRISPR: development of a technology and its applications | |
DE60009547T2 (en) | Process for the poration of biological membranes | |
Ramaswamy et al. | Enhanced thermal effects under microwave heating conditions | |
Costa et al. | Rapid decomposition of a cationic azo‐initiator under microwave irradiation | |
JP2007029096A (en) | Analysis method and apparatus | |
EP1748084A1 (en) | Analytical method and device | |
Vitzthum et al. | Amplifiable DNA from Gram-negative and Gram-positive bacteria by a low strength pulsed electric field method | |
McBee | Innovative methods of energy transfer | |
Giberson et al. | Days can be converted to hours, minutes or even seconds when using microwave technology in the Lab | |
Atwater et al. | A microwave‐powered sterilizable interface for aseptic access to bioreactors that are vulnerable to microbial contamination | |
US20230071935A1 (en) | Microplate cycling thermo sonicator with programmable ultrasound, heating, and cooling for multi-analytical applications | |
GB1569926A (en) | Sterilisation of sludges | |
JP3160903B2 (en) | Heat sterilization method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AU CA JP US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1997938302 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1997938302 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: JP Ref document number: 1998510025 Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 09242349 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 1997938302 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: CA |